Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KLF5 |
| Upstream (Parents) |
|---|
| (<<) ATF5 → KLF5 |
| (<<) NFE2L3 → KLF5 |
| (<<) SOX9 → KLF5 |
| (<<) MYC → KLF5 |
| Downstream (Children) |
|---|
| KLF5 → HOXA9 (>>) |
| KLF5 → CDX2 (>>) |
| KLF5 → HOXA10 (>>) |
| KLF5 → EHF (>>) |
| KLF5 → PRDM2 (>>) |
| KLF5 → GRHL2 (>>) |
| KLF5 → MNX1 (>>) |
| KLF5 → FOXA1 (>>) |
| KLF5 → MSX1 (>>) |
| KLF5 → FOXM1 (>>) |
| KLF5 → VDR (>>) |
| KLF5 → RBPJL (>>) |
| KLF5 → E2F8 (>>) |
| KLF5 → PEG3 (>>) |
| KLF5 → NFAT5 (>>) |
| KLF5 → YY1 (>>) |
| KLF5 → JUN (>>) |
| KLF5 → MSL3 (>>) |
| KLF5 → RB1 (>>) |
| KLF5 → BCL11B (>>) |
| KLF5 → TAF4B (>>) |
| KLF5 → ELF1 (>>) |
| KLF5 → LASS6 (>>) |
